Description
Iverchrist (Ivermectin) 6 mg
Iverchrist 6 mg is a product name for oral ivermectin. Ivermectin is an antiparasitic medicine used against certain nematode and ectoparasite infections. Its recognised medical role is mainly in parasitic disease, not in routine treatment of viral or bacterial infections.
Active Ingredient and Medicine Class
The verified active ingredient is ivermectin, a macrocyclic lactone anthelmintic and antiparasitic agent. It is a member of the avermectin class and acts selectively on invertebrate nerve and muscle function.
Established Medical Uses
Official prescribing information for ivermectin tablets identifies treatment of intestinal strongyloidiasis due to Strongyloides stercoralis. Broader human use described in regulatory and review sources includes certain parasitic infections such as onchocerciasis, lymphatic filariasis, scabies, and pediculosis, depending on the country and formulation.
How It Works
Ivermectin works by binding to parasite-specific chloride channel systems, especially glutamate-gated chloride channels. This disrupts nerve and muscle signalling in susceptible parasites, leading to paralysis and death. The selectivity for parasites is related to differences between invertebrate and vertebrate ion channel biology.
Important Safety Information
Ivermectin tablets are contraindicated in people with known hypersensitivity to the medicine or any component of the formulation. Safety warnings in prescribing information highlight that patients with onchocerciasis may experience inflammatory reactions related to parasite death, including skin, eye, or systemic symptoms.
Clinically significant interactions may occur with medicines that affect drug transport or metabolism, including strong P-glycoprotein and CYP3A4 inhibitors or inducers, because ivermectin exposure may change. Caution is also warranted in people with major liver disease or conditions that increase the risk of central nervous system adverse effects.
Possible Side Effects
Commonly reported adverse effects include dizziness, nausea, diarrhoea, abdominal discomfort, itching, and rash. In parasitic infections, some symptoms may reflect the body’s response to dying parasites rather than a direct drug effect. Serious reactions are uncommon but can include severe hypersensitivity, neurological effects, hypotension, and worsening inflammatory reactions in specific infections such as onchocerciasis or loiasis.
Scientific Evidence
Human evidence supports ivermectin as an established antiparasitic medicine, particularly for strongyloidiasis and other selected helminth or ectoparasitic infections. Reviews and clinical studies also show that its effectiveness depends on the specific parasite and disease setting, and that not all proposed uses have the same level of evidence.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / U.S. prescribing information: “Ivermectin Tablets, USP” — official drug label
- P. González et al. “Ivermectin in human medicine, an overview of the current status of its clinical applications.” Current Pharmaceutical Biotechnology (2012). PubMed
